Last reviewed · How we verify
Single Ascending Doses of EB8018 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Single Ascending Doses of EB8018 (Single Ascending Doses of EB8018) — Enterome.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Single Ascending Doses of EB8018 TARGET | Single Ascending Doses of EB8018 | Enterome | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Single Ascending Doses of EB8018 CI watch — RSS
- Single Ascending Doses of EB8018 CI watch — Atom
- Single Ascending Doses of EB8018 CI watch — JSON
- Single Ascending Doses of EB8018 alone — RSS
Cite this brief
Drug Landscape (2026). Single Ascending Doses of EB8018 — Competitive Intelligence Brief. https://druglandscape.com/ci/single-ascending-doses-of-eb8018. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab